<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>antidiabetics</title><link>http://www.unboundmedicine.com/medline/ebm/research/antidiabetics</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: A retrospective cohort study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19922889/full_citation/Predictors_of_medication_nonadherence_among_patients_with_diabetes_in_Medicare_Part_D_programs:_A_retrospective_cohort_study_</link><description>Yang Y, Thumula V, Pace PF, et al. <br/><span class="title">Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: A retrospective cohort study. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinical therapeutics">Clin Ther 2009 Oct; 31(10):2178-2188.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19922889/abstract/Predictors_of_medication_nonadherence_among_patients_with_diabetes_in_Medicare_Part_D_programs:_A_retrospective_cohort_study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19922889/full_citation/Predictors_of_medication_nonadherence_among_patients_with_diabetes_in_Medicare_Part_D_programs:_A_retrospective_cohort_study_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19922889/Predictors_of_medication_nonadherence_among_patients_with_diabetes_in_Medicare_Part_D_programs:_A_retrospective_cohort_study_">Find Related Articles</a> </description></item><item><title>Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19921965/full_citation/Persistence_with_injectable_antidiabetic_agents_in_members_with_type_2_diabetes_in_a_commercial_managed_care_organization_</link><description>Cooke CE, Lee HY, Tong YP, et al. <br/><span class="title">Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization. [JOURNAL ARTICLE]</span><br/><span class="source" title="Current medical research and opinion">Curr Med Res Opin 2009 Nov 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19921965/abstract/Persistence_with_injectable_antidiabetic_agents_in_members_with_type_2_diabetes_in_a_commercial_managed_care_organization_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19921965/full_citation/Persistence_with_injectable_antidiabetic_agents_in_members_with_type_2_diabetes_in_a_commercial_managed_care_organization_">Full Citation</a></description></item><item><title>[Use of oral hypoglycemic agents in patients with chronic kidney failure.]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19918750/full_citation/[Use_of_oral_hypoglycemic_agents_in_patients_with_chronic_kidney_failure_]</link><description>Libardi F, Sirolli V, Cappelli P, et al. <br/><span class="title">[Use of oral hypoglycemic agents in patients with chronic kidney failure.] [English Abstract, Journal Article]</span><br/><span class="source" title="Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia">G Ital Nefrol 2009 Nov-Dec; 26(6):679-85.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19918750/abstract/[Use_of_oral_hypoglycemic_agents_in_patients_with_chronic_kidney_failure_]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19918750/full_citation/[Use_of_oral_hypoglycemic_agents_in_patients_with_chronic_kidney_failure_]">Full Citation</a></description></item><item><title>Role of continuous subcutaneous insulin infusion in patients with recalcitrant diabetes in South India.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19905890/full_citation/Role_of_continuous_subcutaneous_insulin_infusion_in_patients_with_recalcitrant_diabetes_in_South_India_</link><description>Sudhakaran C, Anjana RM, Rao K, et al. <br/><span class="title">Role of continuous subcutaneous insulin infusion in patients with recalcitrant diabetes in South India. [Journal Article]</span><br/><span class="source" title="Diabetes technology &amp; therapeutics">Diabetes Technol Ther 2009 Nov; 11(11):733-7.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19905890/abstract/Role_of_continuous_subcutaneous_insulin_infusion_in_patients_with_recalcitrant_diabetes_in_South_India_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19905890/full_citation/Role_of_continuous_subcutaneous_insulin_infusion_in_patients_with_recalcitrant_diabetes_in_South_India_">Full Citation</a></description></item><item><title>Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19875578/full_citation/Is_there_evidence_that_oral_hypoglycemic_agents_reduce_cardiovascular_morbidity/mortality_Yes_</link><description>Bianchi C, Miccoli R, Daniele G, et al. <br/><span class="title">Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes. [Journal Article]</span><br/><span class="source" title="Diabetes care">Diabetes Care 2009 Nov.:S342-8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19875578/full_citation/Is_there_evidence_that_oral_hypoglycemic_agents_reduce_cardiovascular_morbidity/mortality_Yes_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19875578/Is_there_evidence_that_oral_hypoglycemic_agents_reduce_cardiovascular_morbidity/mortality_Yes_">Find Related Articles</a> </description></item><item><title>Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity or mortality? No.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19875577/full_citation/Is_there_evidence_that_oral_hypoglycemic_agents_reduce_cardiovascular_morbidity_or_mortality_No_</link><description>Kassem SA, Raz I <br/><span class="title">Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity or mortality? No. [Comment, Journal Article]</span><br/><span class="source" title="Diabetes care">Diabetes Care 2009 Nov.:S337-41.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19875577/full_citation/Is_there_evidence_that_oral_hypoglycemic_agents_reduce_cardiovascular_morbidity_or_mortality_No_">Full Citation</a></description></item><item><title>Initiating insulin therapy in type 2 diabetic patients failing on oral hypoglycemic agents: basal or prandial insulin? The APOLLO trial and beyond.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19875561/full_citation/Initiating_insulin_therapy_in_type_2_diabetic_patients_failing_on_oral_hypoglycemic_agents:_basal_or_prandial_insulin_The_APOLLO_trial_and_beyond_</link><description>Bretzel RG, Eckhard M, Landgraf W, et al. <br/><span class="title">Initiating insulin therapy in type 2 diabetic patients failing on oral hypoglycemic agents: basal or prandial insulin? The APOLLO trial and beyond. [Journal Article]</span><br/><span class="source" title="Diabetes care">Diabetes Care 2009 Nov.:S260-5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19875561/full_citation/Initiating_insulin_therapy_in_type_2_diabetic_patients_failing_on_oral_hypoglycemic_agents:_basal_or_prandial_insulin_The_APOLLO_trial_and_beyond_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19875561/Initiating_insulin_therapy_in_type_2_diabetic_patients_failing_on_oral_hypoglycemic_agents:_basal_or_prandial_insulin_The_APOLLO_trial_and_beyond_">Find Related Articles</a> </description></item><item><title>Thyroid Hormone Induced Brown Adipose Tissue and Amelioration of Diabetes in a Patient with Extreme Insulin Resistance.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19897683/full_citation/Thyroid_Hormone_Induced_Brown_Adipose_Tissue_and_Amelioration_of_Diabetes_in_a_Patient_with_Extreme_Insulin_Resistance_</link><description>Skarulis MC, Celi FS, Mueller E, et al. <br/><span class="title">Thyroid Hormone Induced Brown Adipose Tissue and Amelioration of Diabetes in a Patient with Extreme Insulin Resistance. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Journal of clinical endocrinology and metabolism">J Clin Endocrinol Metab 2009 Nov 6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19897683/abstract/Thyroid_Hormone_Induced_Brown_Adipose_Tissue_and_Amelioration_of_Diabetes_in_a_Patient_with_Extreme_Insulin_Resistance_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19897683/full_citation/Thyroid_Hormone_Induced_Brown_Adipose_Tissue_and_Amelioration_of_Diabetes_in_a_Patient_with_Extreme_Insulin_Resistance_">Full Citation</a> | <a href="http://jcem.endojournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=19897683">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19897683/Thyroid_Hormone_Induced_Brown_Adipose_Tissue_and_Amelioration_of_Diabetes_in_a_Patient_with_Extreme_Insulin_Resistance_">Find Related Articles</a> </description></item><item><title>Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19891554/full_citation/Presence_of_CYP2C9_3_allele_increases_risk_for_hypoglycemia_in_Type_2_diabetic_patients_treated_with_sulfonylureas_</link><description>Ragia G, Petridis I, Tavridou A, et al. <br/><span class="title">Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas. [Journal Article]</span><br/><span class="source" title="Pharmacogenomics">Pharmacogenomics 2009 Nov; 10(11):1781-7.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19891554/abstract/Presence_of_CYP2C9_3_allele_increases_risk_for_hypoglycemia_in_Type_2_diabetic_patients_treated_with_sulfonylureas_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19891554/full_citation/Presence_of_CYP2C9_3_allele_increases_risk_for_hypoglycemia_in_Type_2_diabetic_patients_treated_with_sulfonylureas_">Full Citation</a></description></item><item><title>Images in clinical medicine. Injection-site lipoatrophy.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19890122/full_citation/Images_in_clinical_medicine__Injection_site_lipoatrophy_</link><description>Sackey AH <br/><span class="title">Images in clinical medicine. Injection-site lipoatrophy. [Case Reports, Journal Article]</span><br/><span class="source" title="The New England journal of medicine">N Engl J Med 2009 Nov 5; 361(19):e41.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19890122/full_citation/Images_in_clinical_medicine__Injection_site_lipoatrophy_">Full Citation</a> | <a href="http://content.nejm.org/cgi/pmidlookup%3fview=short%26amp;pmid=19890122%26amp;promo=ONFLNS19">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19890122/Images_in_clinical_medicine__Injection_site_lipoatrophy_">Find Related Articles</a> </description></item></channel></rss>